Pharmasia News.com

ALL
News
Opinion
Photos
Videos

Jump to

US Cong probe unusual, may add more drug players: PharmAsia

According to Vikas Dandekar, the scale of investigation by the US Congress is unprecedented and so 10 drugs and 14 generic companies as of now looks like a representative figure.
DRL-GSK generic formulations deal under review: PharmAsia

The DRL-GSK deal was to sell branded generic formulations in emerging markets and was entered into in 2009.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Pharmasia News.com

US Cong probe unusual, may add more drug players: PharmAsia

DRL-GSK generic formulations deal under review: PharmAsia